Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 "ASPECT-2"


Phase N/A Results


The primary endpoint was reached in 9% patients on aspirin, 5% on anticoagulants (p=0.0479), and 5% on combination therapy (p=0.03). Major bleeding was recorded in 3 patients on aspirin, 3 on anticoagulants (p=1.0), and 7 on combination therapy (p=0.2). Minor bleeding was significanty higher in patients using the combination therapy.